A critical role for p130Cas in the progression of pulmonary hypertension in humans and rodents

L. Tu, F. de Man, B. Girerd, M.C. Chaumais, F. Lecerf, C. Francois, F. Perros, P. Dorfmuller, E. Fadel, D. Montani, M. Humbert, E. Saadia, C. Guignabert (Le Plessis-Robinson, Orsay, Clamart, France; Amsterdam, Netherlands)

Source: Annual Congress 2012 - Pulmonary circulation: basic mechanisms, animal models and cell biology
Session: Pulmonary circulation: basic mechanisms, animal models and cell biology
Session type: Poster Discussion
Number: 3179
Disease area: Interstitial lung diseases, Pulmonary vascular diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
L. Tu, F. de Man, B. Girerd, M.C. Chaumais, F. Lecerf, C. Francois, F. Perros, P. Dorfmuller, E. Fadel, D. Montani, M. Humbert, E. Saadia, C. Guignabert (Le Plessis-Robinson, Orsay, Clamart, France; Amsterdam, Netherlands). A critical role for p130Cas in the progression of pulmonary hypertension in humans and rodents. Eur Respir J 2012; 40: Suppl. 56, 3179

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
The emerging role of epigenetics in pulmonary hypertension
Source: Eur Respir J 2016; 48: 903-917
Year: 2016



Contribution of inflammation and impaired angiogenesis to the pathobiology of chronic thromboembolic pulmonary hypertension
Source: Eur Respir J 2015; 46: 431-443
Year: 2015



The dual role of apoptosis in pulmonary hypertension
Source: Research Seminar 2005 - Pulmonary Circulation: Molecular Determinants of Pulmonary Vascular Remodelling
Year: 2005


Impact of pulmonary vascular volume on mortality in IPF: is it time to reconsider the role of vasculature in disease pathogenesis and progression?
Source: Eur Respir J , 49 (2) 1602524; DOI: 10.1183/13993003.02524-2016
Year: 2017


Impact of pulmonary vascular volume on mortality in IPF: is it time to reconsider the role of vasculature in disease pathogenesis and progression?
Source: Eur Respir J , 49 (2) 1602345; DOI: 10.1183/13993003.02345-2016
Year: 2017


The role of viruses in the pathogenesis of pulmonary fibrosis
Source: Virtual Congress 2021 – Viral infections trigger chronic lung damage and disease
Year: 2021


Can ADMA play a role in determining pulmonary hypertension related to chronic obstructive lung disease?
Source: International Congress 2016 – Pulmonary hypertension in lung disease
Year: 2016

PAH and inflammation: its role in pathogenesis - is it of value to modulate it?
Source: Annual Congress 2005 - Challenges in the biological understanding of pulmonary arterial hypertension
Year: 2005

The role of infection in the pathogenesis of idiopathic pulmonary fibrosis},
Source: Eur Respir Rev 2013; 22: 376-381
Year: 2013



How does inflammation contribute to pulmonary hypertension?
Source: Eur Respir J, 51 (1) 1702403; 10.1183/13993003.02403-2017
Year: 2018



Uric acid contributes to the progression of pulmonary hypertension in rodents and humans
Source: International Congress 2018 – Pathobiology of pulmonary hypertension
Year: 2018



Early origins of chronic pulmonary disease: the role of the adult pulmonologist
Source: Virtual Congress 2020 – Chronic respiratory diseases and their origins in early life: how physiology meets clinical medicine
Year: 2020


A potential role for sildenafil in the management of pulmonary hypertension associated with parenchymal lung disease
Source: Eur Respir J 2006; 28: Suppl. 50, 425s
Year: 2006

Role of anti-proliferative therapy in PAH
Source: Research Seminar 2008 - The Pulmonary Circulation: Scleroderma-Related Pulmonary Arterial Hypertension
Year: 2008


Early life influences on the development of chronic pulmonary diseases: the role of the paediatrician
Source: Virtual Congress 2020 – Chronic respiratory diseases and their origins in early life: how physiology meets clinical medicine
Year: 2020


Novel treatment for pulmonary vascular disease: lessons from pathophysiology
Source: Annual Congress 2006 - Molecular pathology: an approach to lung diseases
Year: 2006


How to detect disease progression in pulmonary arterial hypertension
Source: Eur Respir Rev 2012; 21: 40-47
Year: 2012



Regulation of inflammation process in chronic thromboembolic pulmonary hypertension: a potential role of platelet-activating factor-acetylhydrolase
Source: Annual Congress 2006 - Pulmonary circulation: inflammation and remodelling
Year: 2006


CFTR involvement in the pathogenesis of pulmonary arterial hypertension
Source: Virtual Congress 2020 – Experimental approaches to pulmonary hypertension
Year: 2020